Pilot study to investigate the clinical effect of orally inhaled AP301 on treatment of primary graft dysfunction (PGD) in mechanically ventilated patients after primary lung transplantation
Phase of Trial: Phase II
Latest Information Update: 05 Oct 2015
At a glance
- Drugs Solnatide (Primary)
- Indications Reperfusion injury
- Focus Therapeutic Use
- Sponsors APEPTICO Forschung und Entwicklung
- 23 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 06 Oct 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 07 Jan 2014 New trial record